Athero Review - Issue 2/2022
Editorial
63
Reviews
67
Lysosomal acid lipase deficiency – differential diagnosis and treatment options in 2022
Zuzana Urbanová, Věra Malinová, Tomáš Freiberger, Lukáš Tichý, Michal Vrablík
71
82
Impact of SGLT2 inhibitors on cardiovascular disease
Hana Rosolová
85
Benefits of GLP-1 receptor agonists therapy for patients with cardiovascular disease
Martin Haluzík, Michal Vrablík
91
Characteristics of the Czech cohort of patients with familial dysbetalipoproteinemia and evaluation of the applicability of diagnostic algorithms in clinical practice
Martin Šatný, Tereza Altschmiedová, Veronika Todorovová, Ondřej Kyselák, Vladimír Soška, Michal Vrablík
100
GLP-1 receptor agonists and atherosclerosis
Branislav Vohnout, Jana Lisičanová
104
Fats in food pyramids and plates
Jiří Brát
Clinical Studies
110
From International Literature
Announcements
118
25. kongres o ateroskleróze – opět virtuální, opět dobrý
Kristýna Čillíková
Athero Review
2022 Issue 2
Most read in this issue
- Benefits of GLP-1 receptor agonists therapy for patients with cardiovascular disease
- Lysosomal acid lipase deficiency – differential diagnosis and treatment options in 2022
- How are we doing in achieving target LDL-cholesterol levels in the high-risk population in Slovakia: retrospective study
- Lifelong exposure and trajectories of the risk factors – a new direction in prediction of CVD risk